http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016044243-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0128b1ea25bace77f9ff5dc6b2210d7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 |
| filingDate | 2015-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdecce38cdb0a38aaff8b0c06d7832fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b33f01e1dcd6b047713baa2d4150392 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69586642ba4ec4da0ddb412ca56ae5af |
| publicationDate | 2016-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2016044243-A1 |
| titleOfInvention | Pyrimidine nucleoside phosphoramidate |
| abstract | The disclosure describes methods of synthesis of phosphoramidate ester derivatives. Also disclosed are morphic forms of (S) -isopropyl 2- (((S)-(((2R,3R,4R,5R) -5-(5-deutero-2,4- dioxo-3,4-dihydropyrimidin- 1( 2H )-yl)-3,4-dihydroxy-4-methyltetrahydrofuran-2- yl)dideuteromethoxy)-(phenoxy)phosphoryl)amino)propanoate and antiviral therapy using (S) - isopropyl 2- (((S)-(((2R,3R,4R,5R) -5-(5-deutero-2,4-dioxo-3,4-dihydropyrimidin-1( 2H )-yl)-3,4- dihydroxy-4-methyltetrahydrofuran-2-yl)dideuteromethoxy)(phenoxy)phosphoryl)amino)- propanoate (e.g., anti-HCV therapies). |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109476687-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109476687-A |
| priorityDate | 2014-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 213.